Brought to you by 
J&J acquires Conor for $1.26bn
Nov 2006
Executive Summary
J&J will acquire Conor Medsystems (cardiovascular drug delivery devices) for $1.26bn in cash. Conor shareholders will get $33.50 (a 28% premium) for each share they own.
Deal Industry
- Biotechnology
-
Medical Devices
- Implantable Devices
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Site Specific
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Cash
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
J&J acquires Conor for $1.26bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice